Solvay’s Q2 figures look slightly decoupled from Big Chems’ performance as the top-line as well as profitability showed just some slight weakness. Meeting our expectations, the figures were good and confirmed our positive view on the stock. Consensus was beaten. It seems be that the cancellation of the FY guidance in Q1 was only a precautionary measure.
31 Jul 2019
A positive mixture
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A positive mixture
Solvay SA (SOLB:WBO) | 0 0 0.5% | Mkt Cap: 11,953m
- Published:
31 Jul 2019 -
Author:
Martin Schnee -
Pages:
3
Solvay’s Q2 figures look slightly decoupled from Big Chems’ performance as the top-line as well as profitability showed just some slight weakness. Meeting our expectations, the figures were good and confirmed our positive view on the stock. Consensus was beaten. It seems be that the cancellation of the FY guidance in Q1 was only a precautionary measure.